Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis

Journal of the American College of Cardiology

Volumn 35, Issue 1, 2000, Pages 11-18

  Lauer, Bernward ^a   Schannwell, Mira ^b   Kühl, Uwe ^c   Strauer, Bodo Eckhard ^a   Schultheiss, Heinz Peter ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MYOSIN ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; DIASTOLE; DISEASE COURSE; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE RELAXATION; HEART STROKE VOLUME; HEART VENTRICULOGRAPHY; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; SYSTOLE;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOPSY; CHRONIC DISEASE; DIASTOLE; ENDOCARDIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDITIS; MYOSINS; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0033977221     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00485-4     Document Type: Article

References (51)

1. James TN. Myocarditis and cardiomyopathy. N Engl J Med 1983;308:39-41.
2. Fallon JT. Myocarditis and dilated cardiomyopathy: different stages of the same disease? In: Waller B, editor. Contemporary Issues in Cardiovascular Clinics 1987;18:155-62.
3. Kawai C, Matsumon A, Fujiwara H. Myocarditis and dilated cardiomyopathy. Annu Rev Med 1987;38:221-39.
4. Abelmann WH, Lorell BH. The challenge of cardiomyopathy. J Am Coll Cardiol 1989;13:1219-39.
5. Matsumon A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 1996;11:302-9.
6. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of Coxsackie B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;17:1120-3.
7. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH. In situ hybridization of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to diagnosis of viral heart disease. Proc Natl Acad Sci USA 1987;84:6272-6.
8. Pauschinger M, Kühl U, Doerner A, et al. Nachweis enteroviraler RNA in endomyokardialen Biopsien bei inflammatoischer Kardiomyopathie und idiopathischer dilatativer Kardiomyopathie. Z Kardiol 1998;87:443-52.
9. Maisch B, Herzum M, Izumi T, Nunoda S. Importance of humoral and cellular immunological parameters for the pathogenesis of myocarditis. In: Schultheib HP, editor. New Concepts m Viral Heart Disease. Berlin: Springer-Verlag, 1988:259-73.
10. Schultheiss HP. The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy - clinical and experimental data. Springer Semin Immunopathol 1989;11:15-30.
11. Kühl U, Melzner B, Schäfer B, Schultheiss HP, Strauer BE. The Ca channel as cardiac autoantigen. Eur Heart J 1991;12:99-104.
12. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.
13. Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focussing and N-terminal sequence analysis. J Mol Cell Cardiol 1997;29:77-84.
14. Portig I, Pankuweit S, Maisch B. Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1997;29:2245-51.
15. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994;23:146-53.
16. Caforio ALP, Grazzini M, Mann J, et al. Identification of alpha- and beta-myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85:1734-42.
17. Schulze K, Becker FB, Schultheib HP. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 1989;64:179-92.
18. Caforio ALP, Goldman JH, Baig MK, et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997;77:62-7.
19. Liao YH. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. Int J Cardiol 1996;54:165-9.
20. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-13.
21. Billingham MB. Acute myocarditis: a diagnostic dilemma. Br Heart J 1987;58:6-8.
22. Olsen EGJ. The problem of viral heart disease: How often do we miss it? Postgrad Med J 1985;61:479-80.
23. Shanes JG, Ghali J, Billingham ME. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 1987;75:401-5.
24. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimen from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-45.
25. Chow LH, Radio SJ, Sears TD, McManus RM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
26. Cassling RS, Linder J, Sears TD, et al. Quantitative evaluation of inflammation in biopsy specimen from idiopathic failing or irritable hearts: experience in 80 pediatric and adult patients. Am Heart J 1985;110:713-20.
27. Linder J, Cassling RS, Rogler WC, et al. Immunohistochemical characterization of lymphocytes in uninflamed ventricular myocardium. Implications for myocarditis. Arch Pathol Lab Med 1985;109:917-20.
28. Steenbergen C, Kolbeck PC, Wolfe JA, Anthony RM, Sanfilippo FP, Jennings RB. Detection of lymphocytes using Immunohistochemical techniques. Relevance to evaluation of endomyocardial biopsies in suspected cases of lymphocytic myocarditis. J Appl Cardiol 1986;1:63-73.
29. Kühl U, Toussaint M, Ulrich G, Wagner D, Wolff P, Schultheiss HP. Evaluation of immunohistological data for the diagnosis of myocarditis. In: Schultheib, HP, editor. New Concepts in Viral Heart Disease. Berlin: Springer-Verlag, 1988:325-36.
30. Hammond EH, Menlove RL, Anderson JL. Predictive value of immunoflourescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis of myocarditis and idiopathic cardiomyopathy. Am Heart J 1987;114:1055-65.
31. Kühl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE. Dilative Kardiomyopathie-eme chronische Myokarditis? Immunhistologische Charakterisierung lymphozytärer Zellen. Herz 1992;17:97-106.
32. Kühl U, Noutsias M, Seeberg B, et al. Immunohistochemical evidence for a chronic inflammatory process in dilated cardiomyopathy. Heart 1996;75:295-300.
33. Offer G, Moss C, Starr R. A new protein of the thick filament of vertebrate skeletal myofibrils. J Mol Biol 1973;74:653-76.
34. Lompré AM, Schwartz K, d'Albis A, Lacombe G, Thiem NV, Swynghedauw B. Myosin isoenzyme redistribution in chronic cardiac overload. Nature 1979;282:105-7.
35. Dodge HAT, Sandler H, Baxley WA, Hawley RR. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol 1966;18:10-24.
36. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load - dependent relaxation in the intact dog heart. Circ Res 1981;48:813-24.
37. Corin WJ, Murakami T, Monrad S, Hess OM, Krayenbühl HP. Left ventricular passive diastolic properties in chronic mitral regurgitation. Circulation 1990;83:797-807.
38. Murakami T, Hess OM, Gage JE, Grimm J, Krayenbühl HP. Diastolic filling dynamics in patients with aortic stenosis. Circulation 1986;73:1162-74.
39. Krogmann ON, Rammos S, Jakob M, Corin WJ, Hess OM, Bourgeois M. Left ventricular diastolic dysfunction late after coarctation repair in childhood: influence of left ventricular hypertrophy. J Am Coll Cardiol 1993;21:1454-60.
40. Caforio ALP, Goldman JH, Haven AJ, et al. Circulating cardiacspecific autoantibodies as markers for autoimmunity in clinical and biopsy - proven myocarditis. Eur Heart J 1997;18:270-5.
41. Dec W, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1995;333:1564-75.
42. Morimoto S, Hiramitsu S, Yamada K, et al. Clinical and pathologic features of chronic myocarditis: four autopsy cases presenting as dilated cardiomyopathy in life. Am J Cardiovasc Pathol 1992;4:181-91.
43. Vogel WM, Apstein CS, Briggs LL, Gaasch WH, Ahn J. Acute alterations in left ventricular diastolic chamber stiffness. Role of the "erectile" effect of coronary arterial pressure and flow in normal and damaged hearts. Circ Res 1982;51:465-78.
44. Alvarez FL, Neu N, Rose NR, Craig SW, Beisel KW. Heart-specific autoantibodies induced by Coxsackie B3: identification of heart autoantigens. Clin Immun Immunopathol 1987;43:129-39.
45. Neu N, Beisel KW, Traystman MD, Rose NR, Craig SW. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackie virus B3-mduced myocarditis. J Immunol 1987;138:2488-92.
46. Neu N, Rose NR, Beisel KW, Herskovitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;138:3630-6.
47. Schwimmbeck PL, Bland NK, Schultheiss HP. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Eur Heart J 1991;12:76-80.
48. Neu N, Craig SW, Rose NR, Alvarez FL, Beisel KW. Coxsackie virus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol 1987;69:566-74.
49. Limas CJ, Limas C, Goldenberg IF. Possible involvement of the HLA DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J 1995;129:1141-4.
50. Kandolf R, Klingel K, Metschnig H, et al. Molecular studies on enteroviral heart disease: pattern of acute and persistent infection. Eur Heart J 1991;12 Suppl D:49-55.
51. Lauer B, Kühl U, Souvatzoglu M, Vosberg H, Schultheiss HP. Antimyosin-Szintigraphie zur Diagnostik und Verlaufskontrolle bei Patienten mit klinischem Verdacht auf Myokarditis. Z Kardiol 1998;87:691-8.